Compare EQNR & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQNR | ELV |
|---|---|---|
| Founded | 1972 | 1944 |
| Country | Norway | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.3B | 88.0B |
| IPO Year | 2002 | 2001 |
| Metric | EQNR | ELV |
|---|---|---|
| Price | $43.97 | $396.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 19 |
| Target Price | $37.00 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 2.9M | 990.4K |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.08% | 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.73 |
| Revenue | N/A | ★ $199,125,000,000.00 |
| Revenue This Year | $13.35 | N/A |
| Revenue Next Year | N/A | $3.07 |
| P/E Ratio | ★ $14.56 | $27.06 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $22.26 | $274.89 |
| 52 Week High | $45.84 | $436.24 |
| Indicator | EQNR | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 54.76 | 45.06 |
| Support Level | $35.34 | $386.93 |
| Resistance Level | $45.84 | $407.67 |
| Average True Range (ATR) | 0.92 | 9.28 |
| MACD | -0.31 | -2.08 |
| Stochastic Oscillator | 55.65 | 19.49 |
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2025 (50% liquids) and ended 2025 with 5.2 billion barrels of proven reserves (45% liquids). Operations also include oil refineries and natural gas processing, marketing, and trading. The renewables portfolio includes offshore and onshore wind and solar, with total power generation of 5.65 TWh in 2025.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.